Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05756283
Other study ID # PREHAAAB Trial
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 2023
Est. completion date September 2027

Study information

Verified date February 2023
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact Heather Gill, MD
Phone +1 514.934.1934
Email heather.gill@mail.mcgill.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An abdominal aortic aneurysm is a condition where the major artery in the abdomen becomes larger than usual. Over time, as it continues to grow, the wall of the artery weakens and there is a risk that the artery can burst causing internal bleeding and death. Aortic aneurysms are fixed when they reach a certain size to prevent that outcome. The surgery to fix them is a major, high-risk surgery that is associated with a lot of complications and a slow recovery back to normal. The time between diagnosis and surgery is called the pre-operative period and is a key time to optimize a patient's health in order to ensure the best possible outcomes following surgery. This study will look at whether a multidisciplinary pre-operative program that involves exercise training, nutritional advice and supplementation, and psychosocial support will reduce complications following surgery. This program should decrease complications and speed up a patient's recovery back to normal after surgery. It is also a way for patients to take ownership of their disease and play an active role in their health care journey. The benefits from this program will go beyond the pre-operative time frame, as the habits and knowledge gained will improve their health over their lifetime. This study will also assess the economic impact and cost of a program like this.


Description:

Abdominal aortic aneurysms (AAA) are asymptomatic until they rupture, which carries an 80- 90% mortality. Therefore, AAA are surgically repaired when they reach 5.0 cm in women and 5.5cm in men. Despite advances to surgical technique and peri-operative care, open surgical repair still carries a high incidence of post-operative complications of 30-40%, and a long recovery period. This is largely because the surgery itself is major abdominal surgery, and these patients often have significant comorbidities and low functional status. Multimodal prehabilitation (MP) is a concept that uses the preoperative timeframe (between diagnosis and surgery) to optimize physical, nutritional, and emotional wellbeing to improve a patient's functional status and ability to withstand the stress of surgery. To date, there is no study evaluating the effect of MP on post-operative complications following open AAA repair. The primary objective of this trial is to determine if MP will decrease complications as measured by the comprehensive complication index following open AAA repair compared to standard of care. This trial will also assess the effect of MP on functional capacity, hospital length of stay, 30-day mortality and health related quality of life, as well as to assess cost effectiveness, adherence, and fidelity to the intervention.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 152
Est. completion date September 2027
Est. primary completion date September 2026
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Participants older than 50 years of age awaiting elective open AAA repair with AAA diameter =6.9cm. Participants should have the ability to give informed consent. Exclusion Criteria: - Participants undergoing thoracic, thoracoabdominal and/or perivisceral AAA repair. - Participants with ruptured or symptomatic AAA. - Participants with AAA maximal diameter =7cm. - Physical inability to exercise: severe osteoarthritis, musculoskeletal or neurological impairment that precludes exercise. - Contraindication to exercise: rest systolic blood pressure = 180 mmHg and/or diastolic = 100 mmHg, uncontrolled atrial or ventricular arrythmias or proven exercise induced arrhythmias, unstable angina, unstable or acute heart failure, severe symptomatic valvular stenosis, dynamic left ventricular outflow tract obstruction or other comorbidities that imply clinical instability. - Cognitive impairment that would impede understanding of study procedures, informed consent or study questionnaires or the inability to effectively communicate in English/French/Spanish/Catalan.

Study Design


Intervention

Behavioral:
Multimodal Prehabilitation
EXERCISE Supervised exercise High intensity interval training Strength exercise Home-based exercise / promotion of physical activity Low-moderate intensity aerobic training Inspiratory muscle training Low-moderate intensity strength training NUTRITION: nutrition education and optimization. Intake of 0.4g/kg of whey isolate after every supervised training. PSYCHOSOCIAL: mindfulness, cognitive reframing and coping strategies.

Locations

Country Name City State
Canada MUHC-RIMUHC Royal Victoria Hospital Montréal Quebec

Sponsors (2)

Lead Sponsor Collaborator
McGill University Health Centre/Research Institute of the McGill University Health Centre Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

References & Publications (5)

Barakat HM, Shahin Y, Khan JA, McCollum PT, Chetter IC. Preoperative Supervised Exercise Improves Outcomes After Elective Abdominal Aortic Aneurysm Repair: A Randomized Controlled Trial. Ann Surg. 2016 Jul;264(1):47-53. doi: 10.1097/SLA.0000000000001609. — View Citation

Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293. — View Citation

Fenton C, Tan AR, Abaraogu UO, McCaslin JE. Prehabilitation exercise therapy before elective abdominal aortic aneurysm repair. Cochrane Database Syst Rev. 2021 Jul 8;7(7):CD013662. doi: 10.1002/14651858.CD013662.pub2. — View Citation

Staiger RD, Cimino M, Javed A, Biondo S, Fondevila C, Perinel J, Aragao AC, Torzilli G, Wolfgang C, Adham M, Pinto-Marques H, Dutkowski P, Puhan MA, Clavien PA. The Comprehensive Complication Index (CCI(R)) is a Novel Cost Assessment Tool for Surgical Procedures. Ann Surg. 2018 Nov;268(5):784-791. doi: 10.1097/SLA.0000000000002902. — View Citation

Tew GA, Batterham AM, Colling K, Gray J, Kerr K, Kothmann E, Nawaz S, Weston M, Yates D, Danjoux G. Randomized feasibility trial of high-intensity interval training before elective abdominal aortic aneurysm repair. Br J Surg. 2017 Dec;104(13):1791-1801. doi: 10.1002/bjs.10669. Epub 2017 Oct 9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative complications measured by the Comprehensive Complication Index (CCI) The CCI was developed to address some of the limitations of traditional surgical morbidity reporting, such as only reporting the most severe complication or only picking the most common types of complications. It is scored on a true linear interval scale from 0-100 and incorporates the totality of all complications and their severity experienced by a patient CCI will be measured from admission to 6 weeks postoperatively
Secondary ICU Length of stay Intensive Care Unit length of stay From admission to 6 weeks postoperatively
Secondary Hospital length of stay Days from admission to discharge from the hospital From admission to 6 weeks postoperatively
Secondary Reinterventions Need for surgical reintervention due to surgical complications from surgery day to 6 week postoperatively
Secondary Readmission Readmission to the hospital at 6 weeks and at 1 year postoperatively
Secondary Emergency Room visits Visits to the emergency room with or without admission to the hospital at 6 weeks and at 1 year postoperatively
Secondary 6-Minute Walk Test 6-minute walk test Measured at baseline, preoperatively and 6 weeks postoperatively
Secondary VO2 peak Oxygen consumption at peak exercise Measured at baseline and preoperatively
Secondary VO2 AT Oxygen consumption at anaerobic Threshold Measured at baseline and preoperatively
Secondary VE/VCO2 Minute ventilation/carbon dioxide production Measured at baseline and preoperatively
Secondary Yale physical activity survey (YPAS) Questionnaire of daily physical activity Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively
Secondary SF36 Quality of life questionnaire Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively
Secondary Depression Depression measured by the Hospital Anxiety and Depression questionnaire (HADS) 0 (no depression)- 21 (maximal depression) Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively
Secondary Anxiety Anxiety measured by the Hospital Anxiety and Depression questionnaire (HADS) 0 (no anxiety)- 21 (maximal anxiety) Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively
Secondary Patient Generated Subjective Global Assessment (PG-SGA) Malnutrition assessment tool Measured at baseline, preoperatively
Secondary Compliance to intervention Compliance to the different components of the intervention, measured by attendance to supervised sessions (%), adherence to nutritional counseling and supplementation (%), adherence to home-based exercise (%) and adherence to the psychosocial sessions (%) Measured from baseline to preoperatively
Secondary Fidelity to exercise intervention Real training wattage and kg vs expected Measured from baseline to preoperatively
Secondary Height measurement of height in meters Measured at baseline and preoperatively
Secondary Weight measurement of Weight in kg Measured at baseline and preoperatively
Secondary Body Mass Index (BMI) Measurement of body mass index (weight and height will be combined to report BMI in kg/m^2) Measured at baseline and preoperatively
Secondary Body Fat percentage Measurement of body fat percentage using Bioelectrical Impedance Analysis Measured at baseline and preoperatively
Secondary Fat Free Mass (FFM) Measurement of body fa free mass in kg, using Bioelectrical Impedance Analysis Measured at baseline and preoperatively
Secondary Muscle Mass Measurement of muscle mass in kg, using Bioelectrical Impedance Analysis Measured at baseline and preoperatively
Secondary Phase angle Measurement of phase angle, using Bioelectrical Impedance Analysis Measured at baseline and preoperatively
Secondary Satisfaction and acceptability Intervention satisfaction and acceptability questionnaire Preoperative assessment
Secondary Incidents of adverse events (prehabilitation safety and tolerability) Incidence of adverse events and severe adverse events during prehabilitation program Measured from Baseline to Preoperatively
Secondary Quality adjusted life years Quality adjusted life years derived from SF36 data (SF6D) Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively
Secondary Prehabilitation cost-effectiveness Measurement of prehabilitation cost-effectiveness using data from SF6D, prehabilitation costs and hospitalization related costs. Measured at 1 year postoperatively
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04227054 - Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks N/A
Active, not recruiting NCT03687489 - Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System N/A
Active, not recruiting NCT03507413 - Metformin Therapy in Non-diabetic AAA Patients Phase 2/Phase 3
Not yet recruiting NCT04089241 - Fusion of CT Angiography With 3D Contrast Ultrasound as a Method for Follow up for Endovascular Aneurysm Repair N/A
Active, not recruiting NCT02604303 - A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms
Completed NCT02224794 - LIFE Study: Least Invasive Fast-Track EVAR
Terminated NCT01843335 - Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair N/A
Completed NCT02229006 - Sodium Fluoride Imaging of Abdominal Aortic Aneurysms N/A
Terminated NCT02469376 - Evaluation of a New Imagingtechnologie for Thrombosis Phase 1
Terminated NCT01425242 - Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension N/A
Completed NCT01118520 - AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) Phase 2
Completed NCT00746122 - Immediate Management of the Patient With Rupture : Open Versus Endovascular Repair N/A
Completed NCT03952780 - Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
Completed NCT00583414 - Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients N/A
Recruiting NCT05864560 - Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
Completed NCT01683084 - Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms Phase 4
Active, not recruiting NCT03180996 - Global Fenestrated Anaconda Clinical sTudy
Completed NCT02493296 - The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
Completed NCT03320408 - Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers
Completed NCT03837704 - Comparison of Abdominal Aortic Aneurysm Growth in Adult Smoking Patients Who Either Switch to IQOS, Continue Smoking, or Quit Smoking. N/A